Javier A. Mas-Rosario

Javier A. Mas-Rosario

Auto-generated profile, based on publicly available information

Javier A. Mas-Rosario

University of Massachusetts Amherst

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in ACS Nano
Verified
Journal Article
Closed access
TJTaewon Jeon
Taewon Jeon
DLDavid C. Luther
David C. Luther
RGRitabrita Goswami
Ritabrita Goswami
CBCharlotte Bell
Charlotte Bell
HNHarini Nagaraj
Harini Nagaraj
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello

1 June 2022 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
SDSujeewa S Lellupitiyage Don
Sujeewa S Lellupitiyage Don
JMJavier A Mas-Rosario
Javier A Mas-Rosario
HLHui-Hsien Lin
Hui-Hsien Lin
ENEvelyn M Nguyen
Evelyn M Nguyen
Stephanie TaylorStephanie Taylor
Stephanie Taylor
MFMichelle Farkas
Michelle Farkas
Macrophages are white blood cells that play disparate roles in homeostasis and immune responses. They can reprogram their phenotypes to pro-inflammatory (M1) or anti-inflammatory (M2) states in response to their environment. About 8–15% of the macrophage transcriptome has circadian oscillations, including genes closely related to their functioning. As circadian rhythms are associated with cellular phenotypes, we hypothesized that polarization of macrophages to opposing subtypes might differently affect their circadian rhythms. We tracked circadian rhythms in RAW 264.7 macrophages using luminescent reporters. Cells were stably transfected with Bmal1:luc and Per2:luc reporters, representing positive and negative components of the molecular clock. Strength of rhythmicity, periods and amplitudes of time series were assessed using multiple approaches. M1 polarization decreased amplitudes and rhythmicities of Bmal1:luc and Per2:luc, but did not significantly affect periods, while M2 polarization increased periods but caused no substantial alterations to amplitudes or rhythmicity. As macrophage phenotypes are also altered in the presence of cancer cells, we tested circadian effects of conditioned media from mouse breast cancer cells. Media from highly aggressive 4T1 cells caused loss of rhythmicity, while media from less aggressive EMT6 cells yielded no changes. As macrophages play roles in tumors, and oncogenic features are associated with circadian rhythms, we tested whether conditioned media from macrophages could alter circadian rhythms of cancer cells. Conditioned media from RAW 264.7 cells resulted in lower rhythmicities and periods, but higher amplitudes in human osteosarcoma, U2OS-Per2:luc cells. We show that phenotypic changes in macrophages result in altered circadian characteristics and suggest that there is an association between circadian rhythms and macrophage polarization state. Additionally, our data demonstrate that macrophages treated with breast cancer-conditioned media have circadian phenotypes similar to those of the M1 subtype, and cancer cells treated with macrophage-conditioned media have circadian alterations, providing insight to another level of cross-talk between macrophages and cancer.

23 August 2023 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
SRSiva Kumar Rokkam
Siva Kumar Rokkam
JMJavier A. Mas‐Rosario
Javier A. Mas‐Rosario
BJBishnu P. Joshi
Bishnu P. Joshi
MJMayank Joshi
Mayank Joshi
ACAngshuman Roy Choudhury
Angshuman Roy Choudhury
MFMichelle Farkas
Michelle Farkas

18 March 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJoseph Hardie
Joseph Hardie
JMJavier A. Mas-Rosario
Javier A. Mas-Rosario
SHSiyoung Ha
Siyoung Ha
ERErik M. Rizzo
Erik M. Rizzo
MFMichelle Farkas
Michelle Farkas
Immunotherapy has become a promising new approach for cancer treatment due to the immune system’s ability to remove tumors in a safe and specific manner. Many tumors express anti-inflammatory factors that deactivate the local immune response or recruit peripheral macrophages into pro-tumor roles. Because of this, effective and specific ways of activating macrophages into anti-tumor phenotypes is highly desirable for immunotherapy purposes. Here, the use of a small molecule TLR agonist as a macrophage activator for anti-cancer therapy is reported. This compound, referred to as PBI1, demonstrated unique activation characteristics and expression patterns compared to treatment with LPS, through activation of TLR4. Furthermore, PBI1 treatment resulted in anti-tumor immune behavior, enhancing macrophage phagocytic efficiency five-fold versus non-treated macrophages. Additive effects were observed via use of a complementary strategy (anti-CD47 antibody), resulting in ∼10-fold enhancement of phagocytosis, suggesting this small molecule approach could be used in conjunction with other therapeutics.

27 January 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
RKR. Siva Kumar
R. Siva Kumar
JMJavier Mas-Rosario
Javier Mas-Rosario
BJBishnu Joshi
Bishnu Joshi
MJMayank Joshi
Mayank Joshi
ACAngshuman Roy Choudhury
Angshuman Roy Choudhury
MFMichelle Farkas
Michelle Farkas
There is a significant need for new small molecule anti-inflammatory compounds. Curcumin, a small molecule natural product from the Turmeric (Curcuma longa) plant, has well-known anti-oxidant properties, resulting from its radical scavenging ability and inhibition of inflammation-associated factors. However, its lack of solubility, instability, and poor bioavailability and biodistribution characteristics are an impediment to its use. To circumvent these issues while retaining curcumin’s biological activity, we synthesized twenty-one diarylidene-N-methyl-4-piperidones (DANMPs), four diheteroarylidene-N-methyl-4-piperidones (DHANMPs), and five spirobibenzopyran (SBP) derivatives. All were screened in terms of anti-oxidant activity via a cell-free 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay and for drug-like properties in silico. In the former, some compounds possessed improved radical scavenging behavior versus ascorbic acid, which was used as a benchmark. Conformity to simulated Lipinski’s parameters and Absorption, Distribution, Metabolism, and Excretion (ADME) studies indicated the DANMPs, DHANMPs, and SBPs to be potentially useful compounds. A subset of molecules was investigated in terms of their aqueous solubilities, which were significantly improved compared to that of curcumin. In vitro assessments of the cellular and anti-inflammatory effects of these compounds were conducted using RAW264.7 macrophages. RT-PCR and Griess assays were used to evaluate the presence of inflammatory/activated (M1) markers and production of nitric oxide (NO) species, which are associated with inflammation, respectively. While the compounds did not affect non-stimulated (naïve) macrophages, they did reduce levels of markers and NO to extents similar to or better than curcumin in inflamed cells. Our results indicate that these pharmacophores possess anti-inflammatory properties and can be used as curcumin-substitutes with improved characteristics. Further investigation into their mechanisms of action and potential use in the treatment of inflammatory diseases is merited.